Return to search

The role of MYD88-dependent receptors in the anti-tumor efficacy of the EGFR inhibitor Erlotinib in head and neck cancer

No description available.
Identiferoai:union.ndltd.org:uiowa.edu/oai:ir.uiowa.edu:etd-5384
Date01 July 2014
CreatorsKoch, Adam Taylor
ContributorsSimons-Burnett, Andrean
PublisherUniversity of Iowa
Source SetsUniversity of Iowa
LanguageEnglish
Detected LanguageEnglish
Typethesis
Formatapplication/pdf
SourceTheses and Dissertations
RightsCopyright 2014 Adam Taylor Koch

Page generated in 0.0327 seconds